AdVitam

Genomic AI platform for healthcare professionals and life sciences

Company Overview

Advitam is a genomic AI company building the bridge between cutting-edge research and clinical practice. Powered by the Evo2 foundational model from the Arc Institute and NVIDIA BioNeMo infrastructure, our platform enables healthcare professionals to analyze genetic sequences at single-nucleotide resolution.

Our mission is to democratize genomic analysis to enable more predictive, more precise, and more personalized medicine.

Technology

Evo2 — The Foundational Genomic Model

Developed by the Arc Institute, Evo2 analyzes genetic sequences at the single-nucleotide level, trained on over 9.3 trillion nucleotides from 128,000+ species. The model achieves 90% documented accuracy in distinguishing benign from pathogenic mutations on the BRCA1 gene.

NVIDIA BioNeMo Deployment

Evo2 is available as an NVIDIA NIM microservice, deployable in secure environments — cloud or on-premise — for analyzing private genetic data in full regulatory compliance. Developed on NVIDIA DGX Cloud with 2,000 H100 GPUs, the platform processes sequences up to 1 million nucleotides in a single pass.

Founders

Company Facts

Contact

Media inquiries: press@advitam.ai